Sagent Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT, and what generic and branded alternatives to SAGENT drugs are available?
SAGENT has eighty-eight approved drugs.
There is one tentative approval on SAGENT drugs.
Drugs and US Patents for Sagent
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms | DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 091495-001 | Mar 18, 2013 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms | OXACILLIN SODIUM | oxacillin sodium | INJECTABLE;INJECTION | 091246-001 | Mar 30, 2012 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 203323-001 | May 12, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.